MS-DRG v38 (FY 2021) Definitions Manual • DRG 839 - CHEMOTHERAPY WITH ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITHOUT CC/MCC

DRG Information as of MS-DRG v38 (FY 2021)

MDCMDC 17 Myeloproliferative Diseases & Disorders, Poorly Differentiated Neoplasms
MDC SubsectionChemotherapy
DRG Number839
DRG DescriptionCHEMOTHERAPY WITH ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITHOUT CC/MCC
Surgical / Medical Medical

Table 5 for FY 2021

Weights1.4787
Length of Stay (Geometric Mean)4.4
Length of Stay (Arithmetic Mean)4.9
Special Pay DRGNo
Post-Acute DRGNo

DRG Assignment Logic (From MDC 17 Myeloproliferative Diseases & Disorders, Poorly Differentiated Neoplasms Subsection Chemotherapy)

This DRG is a member of the subsection Chemotherapy. Patients who qualify for Chemotherapy will be grouped this DRG or one of the related DRGs according to the logic below.

View the requirements to qualify.

Quick Actions